Pharma

tough-times-ahead-for-merck-r-d-personnel-as-the-firm-plans-to-axe-several-jobs

Report: Merck to axe several R&D jobs

  • US
  • |
  • News

Singapore: Merck & Co plans to cut jobs at its research laboratories in order to simplify governance so as to advance therapeutic and vaccine candidates more efficiently and focus resources on the most promising programs. The move comes... Read more

duke-cancer-institute-atudy-pfizer-s-osteoporosis-drug-bazedoxifene-can-stop-even-the-most-resistant-breast-cancers

Osteoporosis drug can kill resistant cancer


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A research by Duke Cancer Institute has shown that osteoporosis drug bazedoxifene stops the growth of breast cancer... Read more

equipment

Wohl begins to buy & sell used pharma equipments


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US market leader in used processing and packagng industries, Wohl Associates, has begun to sell used pharmaceutical... Read more

12b-biospectrum-asia-top-20-survey-rank-12-guangzhou-pharmaceutical-china

Guangzhou records a whopping growth of over 50%

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognized name in China, Guangzhou... Read more

11b-biospectrum-asia-top-20-survey-rank-11-lupin-india

Lupin gets 16 FDA nods, launches 11 products front

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11... Read more

dr

Fujifilm, Dr Reddy's terminate generics JV

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter into an exclusive... Read more

9b-biospectrum-asia-top-20-survey-rank-9-dr

Dr. Reddy’s makes a mark in the US generics market

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 percent. Dr. Reddy's... Read more

8b-biospectrum-asia-top-20-survey-rank-8-cipla-india

Cipla keeps the flag high for affordable drugs

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a growth of 17 percent... Read more

ranbaxylab

Ranbaxy advisory: All our products are safe and efficacious

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The... Read more

no-more-monkey-business-satori-pharma-shuts-down-following-alzheimer-s-trial-failure-in-monkeys

Firm shuts after Alzheimer's trial fails in monkeys

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based start-up Satori Pharmaceuticals shut down after running into safety problems in preclinical research of its lead program... Read more

mers-virus-infecting-middle-east

WHO: Coronavirus MERS can be a global killer

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: First identified in September 2012, novel coronavirus MERS, the virus detected in the middle east has now been labeled as a threat... Read more

6b-biospectrum-asia-top-20-survey-rank-6-yunnan-baiyao-china-profile

TCM leader Yunnan Baiyao rides on R&D strength

Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on strengthening its R&D... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X